CATALYST PHARMACEUTICALS, INC. (CPRX) Form 8-K — Jul 8, 2026

$CPRXForm 8-KItems 5.02, 5.07Filed Jul 8, 2026, 5:29 PM ET0001193125-26-298739Original filing

Catalyst Pharmaceuticals stockholders approved the company's merger with Angelini Pharma S.p.A., paving the way for the transaction to close. The proposal received 97.3 million votes in favor, significantly surpassing the votes against and abstentions. All current directors of the Company, including Patrick J. McEnany and Richard J.

Key figures

Shares Outstanding: 122417458
Votes For Merger: 97340180
Abstentions Merger: 242616
Votes Against Merger: 1143815
Votes For Comp Proposal: 30504686
Abstentions Comp Proposal: 735041
Votes Against Comp Proposal: 67486884

Price after filing

1 day: 0.0%7 days: +0.1%

Close on the filing date to close N calendar days later (from $31.47). Historical, not a forecast.

AI analysis

Red flags1 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

Upgrade to Pro · $49/mo billed annually

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.